Citations

Clear

414 citation(s) found for "Collins, S".

High Rate of Missed Lateral Meniscus Posterior Root Tears on Preoperative Magnetic Resonance Imaging
Krych, Aaron J. , Wu, Isabella T. , Desai, Vishal S. , Murthy, Naveen S. , Collins, Mark S., Saris, Daniël B.F. , Levy, Bruce A. , Krych, Aaron J , Desai, Vishal , Stuart, Michael J.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | April 9, 2018 | Volume: 6 | Issue: 4 | Pages: No page available

10.1177/2325967118765722 | PMID 29662913 Get It

Background: Lateral meniscus posterior root tears (LMPRTs), if left untreated, can cause devastating effects to the knee, with rapid articular cartilage degeneration and loss of the meniscus as a secondary stabilizer. Detection and surgical repair of these defects have been linked to favorable outcomes, but preoperative identification of LMPRTs continues to be challenging. Purpose: To determine the rate of LMPRTs diagnosed preoperatively on magnetic resonance imaging (MRI) in a consecutive series of arthroscopically confirmed LMPRTs. Study Design: Case series; Level of evidence, 4. Methods: A retrospective cohort of 45 consecutive patients with arthroscopically confirmed LMPRTs between 2010 and 2017 were included in this study. The preoperative MRI report for each patient was evaluated and compared with intraoperative findings. Each preoperative MRI study was then reviewed by 2 fellowship-trained musculoskeletal radiologists who worked in consensus. Results: A total of 45 patients (32 males, 13 females) with arthroscopically confirmed LMPRTs and a mean age of 27 years (range, 14-54 years) were included in the study. Only 15 of 45 LMPRTs (33%) were initially diagnosed on preoperative MRI. Past or concurrent anterior cruciate ligament (ACL) reconstruction was present in 37 of 45 cases (82%). Upon retrospective review, 15 of the 30 missed LMPRTs were “clearly evident,” 12 “subtly evident,” and 3 “occult” (unavoidably missed). There were no significant differences in the rate of LMPRT diagnosis based on history of prior knee surgery, meniscus extrusion, or tearing of the meniscofemoral ligament. Conclusion: Despite improved identification of other meniscus tear patterns on MRI, a high percentage of LMPRTs were still missed. In the setting of previous ACL reconstruction, if the root cannot be confidently identified, the MRI interpretation should indicate that “the root is poorly visualized” to alert the surgeon to thoroughly evaluate this structure. The surgeon should maintain a high index of suspicion and carefully probe the posterior root of the lateral meniscus at the time of arthroscopy, especially in cases of ACL injury.
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial
Arenas‐Pinto, Alejandro , Grund, Birgit , Sharma, Shweta , Martínez, Estebán , Fox, Julie , Klingman, Karin L. , Collins, Simon , Flynn, Patricia M. , Chasanov, William M, Kedem, Eynat, Katlama, Christine , Sierra‐Madero, Juan , Brouwers, Pim , Cooper, David A., group, INSIGHT START study, Cummins, Nathan, Cummins, Nathan W. , Sedláček, Dalibor , Afonso, Cláudia M. , group, INSIGHT START study

Mayo Clinic

Clinical Infectious Diseases | February 1, 2018 | Volume: 67 | Issue: 3 | Pages: 420-429

10.1093/cid/ciy051 | PMID 29538636 Get It

Phosphaturic effect of L-NMMA in the presence of parathyroid hormone
Onsgard-Meyer, M. J., Kerrigan, R., Khraibi, Ali A. , Knox, Franklyn G., Collins, Michael Terrence

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | December 24, 2017 | Volume: 271 | Issue: 6 | Pages: R1477-R1480

10.1152/ajpregu.1996.271.6.r1477 | PMID 8997342 Get It

The objective of this study was to examine the effect of NG-monomethyl-L-arginine (L-NMMA) on phosphate excretion in the presence and absence of parathyroid hormone (PTH). Renal clearances were obtained before and during infusion of L-NMMA (15 mg/kg bolus and 500 micrograms.kg-1.min-1 infusion) in Sprague-Dawley rats with intact parathyroid glands (n = 6), in thyroparathyroidectomized (TPTX) rats receiving a constant infusion of PTH-(1-34) (0.01-0.03 U.kg-1.min-1) (n = 11) throughout the experiment, or in TPTX rats, that received an acute infusion of PTH-(1-34) (33 U/kg bolus and 1 U.kg-1.min-1 infusion) after L-NMMA infusion alone (n = 7). In rats with intact parathyroid glands, L-NMMA increased the fractional excretions of phosphate (FEPi) and sodium (FENa) and mean arterial pressure (MAP) (delta 8.6 +/- 1.5%, delta 0.62 +/- 0.1%, and delta 26.7 +/- 4.9 mmHg, respectively; P < 0.05). In TPTX rats receiving a constant infusion of PTH, L-NMMA again increased FEPi, FENa, and MAP (delta 9.5 +/- 3.6%, delta 1.1 +/- 0.4%, and delta 28.4 +/- 4.5 mmHg, respectively; P < 0.05). However, in TPTX rats, L-NMMA alone did not increase FEPi (delta 0.9 +/- 0.3%), whereas the subsequent infusion of PTH with L-NMMA increased FEPi (delta 15.6 +/- 3.1%; P < 0.05). In an additional group of intact and TPTX rats, the fractional excretion of lithium (FELi) was measured as an index of proximal reabsorption. L-NMMA increased FELi in intact rats (delta 13.2 +/- 2.6%; P < 0.05), but not in TPTX rats (delta 4.2 +/- 3.3%). In conclusion, L-NMMA increases phosphate excretion in association with increases in MAP and FENa, and this phosphaturic effect is dependent on the presence of PTH.
Alternative Outpatient Chemotherapy Scheduling Method to Improve Patient Service Quality and Nurse Satisfaction
Huang, Yu-Li, Bryce, Alan H. , Culbertson, Tracy, Connor, Sarah L., Looker, Sherry, Altman, Kristin M., Collins, James , Stellner, Winston, Moreno‐Aspitia, Alvaro , Looker, Sherry A, Collins, James G, McWilliams, Robert R. , Bryce, Alan H , Culbertson, Tracy L, Ailawadhi, Sikander , Mesa, Ruben A.

Mayo Clinic

Journal of Oncology Practice | December 22, 2017 | Volume: 14 | Issue: 2 | Pages: e82-e91

10.1200/jop.2017.025510 | PMID 29272201 Get It

Introduction: Optimal scheduling and calendar management in an outpatient chemotherapy unit is a complex process that is driven by a need to focus on safety while accommodating a high degree of variability. Primary constraints are infusion times, staffing resources, chair availability, and unit hours. Methods: We undertook a process to analyze our existing management models across multiple practice settings in our health care system, then developed a model to optimize safety and efficiency. The model was tested in one of the community chemotherapy units. We assessed staffing violations as measured by nurse-to-patient ratios throughout the workday and at key points during treatment. Staffing violations were tracked before and after the implementation of the new model. Results: The new model reduced staffing violations by nearly 50% and required fewer chairs to treat the same number of patients for the selected clinic day. Actual implementation results indicated that the new model leveled the distribution of patients across the workday with an 18% reduction in maximum chair utilization and a 27% reduction in staffing violations. Subsequently, a positive impact on peak pharmacy workload reduced delays by as much as 35 minutes. Nursing staff satisfaction with the new model was positive. Conclusion: We conclude that the proposed optimization approach with regard to nursing resource assignment and workload balance throughout a day effectively improves patient service quality and staff satisfaction.
Surveillance for and Discovery of Borrelia Species in US Patients Suspected of Tickborne Illness
Kingry, Luke C. , Anacker, Melissa , Pritt, Bobbi S. , Bjork, Jenna , Respicio-Kingry, Laurel, Liu, Gong‐Ping , Sheldon, Sarah W., Boxrud, David, Strain, Anna K., Oatman, Stephanie, Berry, Jon, Sloan, Lynne M., Mead, Paul S. , Neitzel, David F., Kugeler, Kiersten J. , Petersen, Jeannine M., Pritt, Bobbi, Sloan, Lynne, Kingry, Luke , Pritt, Bobbi S , Berry, Jonathan

Mayo Clinic

Clinical Infectious Diseases | December 17, 2017 | Volume: 66 | Issue: 12 | Pages: 1864-1871

10.1093/cid/cix1107 | PMID 29272385 Get It

Concordance between administrative data and clinical review for mortality in the randomized on/off bypass follow-up study (ROOBY-FS)
Quin, Jacquelyn A. , Hattler, Brack , Kemp, Darlene, Almassi, G. Hossein , Bakaeen, Faisal G. , Carr, Brendan M. , Bishawi, Muath , Collins, Joseph F. , Grover, Frederick L., Wagner, Todd H. , Shroyer, A. Laurie

Mayo Clinic

Journal of Cardiac Surgery | December 13, 2017 | Volume: 32 | Issue: 12 | Pages: 751-756

10.1111/jocs.13379 | PMID 29239024 Get It

Erratum: Arthritis Progression on Serial MRIs Following Diagnosis of Medial Meniscal Posterior Horn Root Tear
Johnson, Nick, Mohan, Rohith , Littrell, Laurel A. , Collins, Mark S., Krych, Aaron J. , Johnson, Nick R., Krych, Aaron J , Hevesi, Mario , Stuart, Michael J.

Mayo Clinic

The Journal of Knee Surgery | October 11, 2017 | Volume: 31 | Issue: 07 | Pages: e1-e1

10.1055/s-0037-1607351 | PMID 29020692 Get It

Seven tips for developing and maintaining a high performance sports medicine team
Gabbett, Tim J. , Kearney, Simon, Bisson, Leslie J. , Sikka, Robby , Winder, Nathan, Sedgwick, Craig, Hollis, Ed , Bettle, Jeremy M., Collins, Joe T.

Mayo Clinic

British Journal of Sports Medicine | September 27, 2017 | Volume: 52 | Issue: 10 | Pages: 626-627

10.1136/bjsports-2017-098426 | PMID 28954792 Get It

Arthritis Progression on Serial MRIs Following Diagnosis of Medial Meniscal Posterior Horn Root Tear
Johnson, Nick, Mohan, Rohith , Littrell, Laurel A. , Collins, Mark S., Krych, Aaron J. , Johnson, Nick R., Krych, Aaron J , Hevesi, Mario , Stuart, Michael J.

Mayo Clinic

The Journal of Knee Surgery | September 26, 2017 | Volume: 31 | Issue: 07 | Pages: 698-704

10.1055/s-0037-1607038 | PMID 28950387 Get It

AbstractMedial meniscus posterior root tears (MMPRTs) are a significant source of pain and dysfunction. The purpose of this study was to evaluate changes in the medial compartment of the knee over time following the diagnosis of a MMPRT on MRI. A retrospective review of the institutional database was performed for patients with an initial MRI diagnosis of a MMPRT. Patients were included if they had a subsequent follow-up MRI on the same knee. Patients with surgical intervention, including debridement or repair, were excluded. MRIs were evaluated by two board-certified musculoskeletal radiologists. MMPRTs were defined using the LaPrade classification, and the medial compartment articular cartilage was graded using the modified Outerbridge classification. MRIs were reviewed for meniscus extrusion, subchondral bone edema, and insufficiency fractures. Patients were divided into two groups for the analysis to account for differences in MRI time intervals. Group 1 had a follow-up MRI within 12 months of initial imaging (subacute group) and Group 2 had a follow-up MRI greater than 12 months after initial imaging (chronic group). Forty-one knees and 82 MRIs were analyzed, including 20 knees/40 MRIs (13 females, 7 males) in the subacute group and 21 knees/42 MRIs (14 females, 7 males) in the chronic group. Subacute patients had a mean age of 59.5 ± 8.8 years and a mean interval of 4.8 ± 2.6 months between MRIs compared with 53.6 ± 11.0 years and 38.2 ± 20.8 months, respectively, for the chronic group. Meniscal extrusion, femoral modified Outerbridge grade, and tibial modified Outerbridge grade worsened between initial and final MRI in both groups (p < 0.05). In both groups, there were no significant differences between initial and final MRIs with regard to the LaPrade classification, insufficiency fracture, or subchondral cysts of the tibia. Progressive meniscus extrusion and medial compartment articular cartilage degeneration were seen in patients with MMPRTs within a year from diagnosis.
First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer
Northfelt, Don W., Mahr, Michael A. , Ralya, Andrew T., Kuffel, Mary J., Buhrow, Sarah A. , Safgren, Stephanie L. , McGovern, Renee M., Black, John L. , Dockter, Travis , Haddad, Tufia C. , Erlichman, Charles , Adjei, Alex A. , Visscher, Dan W., Kipp, Benjamin R. , Liu, Minetta C. , Hawse, John R. , Doroshow, James H. , Collins, Jerry M. , Streicher, Howard , Ames, Matthew M. , Élez, Elena , Reid, Joel M. , Kuffel, Mary, Black, John, Haddad, Tufia, Visscher, Dan, Chalmers, Zachary R, Frampton, Garrett, Ingle, James N. , Safgren, Stephanie L , Goetz, Matthew P. , Suman, Vera J. , Chalmers, Zachary Rockow , Frampton, Garrett M. , Elez, Elena

Mayo Clinic

Journal of Clinical Oncology | August 30, 2017 | Volume: 35 | Issue: 30 | Pages: 3391-3400

10.1200/jco.2017.73.3246 | PMID 28854070 Get It

Purpose Endoxifen is a tamoxifen metabolite with potent antiestrogenic activity. Patients and Methods We performed a phase I study of oral Z-endoxifen to determine its toxicities, maximum tolerated dose (MTD), pharmacokinetics, and clinical activity. Eligibility included endocrine-refractory, estrogen receptor–positive metastatic breast cancer. An accelerated titration schedule was applied until moderate or dose-limiting toxicity occurred, followed by a 3+3 design and expansion at 40, 80, and 100 mg per day. Tumor DNA from serum (circulating cell free [cf); all patients] and biopsies [160 mg/day and expansion]) was sequenced. Results Of 41 enrolled patients, 38 were evaluable for MTD determination. Prior endocrine regimens during which progression occurred included aromatase inhibitor (n = 36), fulvestrant (n = 21), and tamoxifen (n = 15). Patients received endoxifen once daily at seven dose levels (20 to 160 mg). Dose escalation ceased at 160 mg per day given lack of MTD and endoxifen concentrations > 1,900 ng/mL. Endoxifen clearance was unaffected by CYP2D6 genotype. One patient (60 mg) had cycle 1 dose-limiting toxicity (pulmonary embolus). Overall clinical benefit rate (stable > 6 months [n = 7] or partial response by RECIST criteria [n = 3]) was 26.3% (95% CI, 13.4% to 43.1%) including prior tamoxifen progression (n = 3). cfDNA mutations were observed in 13 patients ( PIK3CA [n = 8], ESR1 [n = 5], TP53 [n = 4], and AKT [n = 1]) with shorter progression-free survival ( v those without cfDNA mutations; median, 61 v 132 days; log-rank P = .046). Clinical benefit was observed in those with ESR1 amplification (tumor; 80 mg/day) and ESR1 mutation (cfDNA; 160 mg/day). Comparing tumor biopsies and cfDNA, some mutations ( PIK3CA, TP53, and AKT) were undetected by cfDNA, whereas cfDNA mutations ( ESR1, TP53, and AKT) were undetected by biopsy. Conclusion In endocrine-refractory metastatic breast cancer, Z-endoxifen provides substantial drug exposure unaffected by CYP2D6 metabolism, acceptable toxicity, and promising antitumor activity.